Abstract
For the pharmacological treatment of frequency, urgency and/or urge incontinence due to bladder overactivity, anticholinergics have been used as first-choice drugs. However, these drugs can exert severe side effects (accommodation paralysis, constipation, tachycardia, dry mouth and blurred vision) and some patients are refractory to their actions. Thus there is a need for new drug therapies with novel mechanisms of action. β-Adrenoceptors are found in the body of the bladder, where they mediate relaxation of the detrusor muscle. It has been reported that β3-adrenoceptor subtypes are predominantly present in the smooth muscles of bladder and urethra in the pig and human. Recently, β3-adrenoceptors have been reported to predominantly mediate relaxation of the bladder smooth muscle. However, the relaxant effects of β3-adrenoceptor agonists are half of those of (±)isoproterenol, a non-selective - adrenoceptor agonist, and the antagonist affinity of β3-adrenoceptor antagonists varies according to the drugs tested. It has also been suggested that both β2-, and β3-adrenoceptors are involved in relaxation of the human bladder, but the involvement of the β3-adrenoceptor may be greater than that of β2-adrenoceptor. Another possibility is that other -adrenoceptors, possibly β4-adrenoceptor and/or atypical β-adrenoceptors, may coexist and play a functional role in mediating the relaxation of the bladder.
Keywords: β-adrenoceptor, subtype, bladder, smooth muscle, overactive bladder
Current Drug Therapy
Title: Which β-Adrenoceptor Subtypes are Important in the Treatment of Overactive Bladder?
Volume: 2 Issue: 1
Author(s): Tomonori Yamanishi, Takao Kamai, Ryuji Sakakibara, Tomoyuki Uchiyama, Tatsuya Yamamoto, Takashi Ito and Ken-ichiro Yoshida
Affiliation:
Keywords: β-adrenoceptor, subtype, bladder, smooth muscle, overactive bladder
Abstract: For the pharmacological treatment of frequency, urgency and/or urge incontinence due to bladder overactivity, anticholinergics have been used as first-choice drugs. However, these drugs can exert severe side effects (accommodation paralysis, constipation, tachycardia, dry mouth and blurred vision) and some patients are refractory to their actions. Thus there is a need for new drug therapies with novel mechanisms of action. β-Adrenoceptors are found in the body of the bladder, where they mediate relaxation of the detrusor muscle. It has been reported that β3-adrenoceptor subtypes are predominantly present in the smooth muscles of bladder and urethra in the pig and human. Recently, β3-adrenoceptors have been reported to predominantly mediate relaxation of the bladder smooth muscle. However, the relaxant effects of β3-adrenoceptor agonists are half of those of (±)isoproterenol, a non-selective - adrenoceptor agonist, and the antagonist affinity of β3-adrenoceptor antagonists varies according to the drugs tested. It has also been suggested that both β2-, and β3-adrenoceptors are involved in relaxation of the human bladder, but the involvement of the β3-adrenoceptor may be greater than that of β2-adrenoceptor. Another possibility is that other -adrenoceptors, possibly β4-adrenoceptor and/or atypical β-adrenoceptors, may coexist and play a functional role in mediating the relaxation of the bladder.
Export Options
About this article
Cite this article as:
Yamanishi Tomonori, Kamai Takao, Sakakibara Ryuji, Uchiyama Tomoyuki, Yamamoto Tatsuya, Ito Takashi and Yoshida Ken-ichiro, Which β-Adrenoceptor Subtypes are Important in the Treatment of Overactive Bladder?, Current Drug Therapy 2007; 2 (1) . https://dx.doi.org/10.2174/157488507779422329
DOI https://dx.doi.org/10.2174/157488507779422329 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Snake Venom Proteins: Development into Antimicrobial and Wound Healing Agents
Mini-Reviews in Organic Chemistry The Small Heat Shock Protein HspB8: Role in Nervous System Physiology and Pathology
CNS & Neurological Disorders - Drug Targets Recent Developments in the Regulation of Monoamine Oxidase Form and Function: Is the Current Model Restricting Our Understanding of the Breadth of Contribution of Monoamine Oxidase to Brain [dys]Function?
Current Topics in Medicinal Chemistry Identification and Characterization of a Chemical Compound that Inhibits Methionyl-tRNA Synthetase from <i>Pseudomonas aeruginosa</i>
Current Drug Discovery Technologies Current Position on the Role of Monomeric C-reactive Protein in Vascular Pathology and Atherothrombosis
Current Pharmaceutical Design First-Principles Modeling of Biological Systems and Structure-Based Drug-Design
Current Computer-Aided Drug Design Cross Talk between the Cardiovascular and Nervous Systems:Neurotrophic Effects of Vascular Endothelial Growth Factor (VEGF) and Angiogenic Effects of Nerve Growth Factor (NGF)-Implications in Drug Development
Current Pharmaceutical Design Current Advances in Delivery of Biotherapeutics Across the Blood-Brain Barrier
Current Drug Discovery Technologies Acute Phase Proteins In Atherosclerosis (Acute Coronary Syndrome)
Cardiovascular & Hematological Agents in Medicinal Chemistry Effect of Cytostatic Drugs on the mRNA Expression Levels of Ribonuclease κ in Breast and Ovarian Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Cardiac and Pulmonary Manifestations in the Antiphospholipid Syndrome
Current Rheumatology Reviews Travelers’ Diarrhea: A Clinical Review
Recent Patents on Inflammation & Allergy Drug Discovery Improved Anti-inflammatory Activity and Potential Cytoprotective Properties of Tolfenamic Acid, Naproxen and Indomethacin Derivatives
Letters in Drug Design & Discovery Silymarin in the Prevention and Treatment of Liver Diseases and Primary Liver Cancer
Current Pharmaceutical Biotechnology Neuron-to-microglia Crosstalk in Psychiatric Disorders
Current Neuropharmacology Herpes Labialis: An Update
Recent Patents on Inflammation & Allergy Drug Discovery In Vitro Comparative Evaluation of Non-Leaves and Leaves Extracts of Andrographis paniculata on Modulation of Inflammatory Mediators
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Gastrointestinal Sparing Anti-Inflammatory Drugs - Effects on Ulcerogenic and Healing Responses
Current Pharmaceutical Design C-Reactive Protein: Interaction with the Vascular Endothelium and Possible Role in Human Atherosclerosis
Current Pharmaceutical Design Cell Signaling Mechanisms of Gustatory Perception of Lipids: Can the Taste Cells be the Target of Anti-obesity Agents?
Current Medicinal Chemistry